• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高维建模以提高诊断测试准确性:基于多重唾液的SARS-CoV-2抗体检测的理论与实例

Modeling in higher dimensions to improve diagnostic testing accuracy: theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays.

作者信息

Luke Rayanne A, Kearsley Anthony J, Pisanic Nora, Manabe Yukari C, Thomas David L, Heaney Christopher D, Patrone Paul N

机构信息

Johns Hopkins University, Whiting School of Engineering, Department of Applied Mathematics and Statistics, Baltimore, MD.

National Institute of Standards and Technology, Applied and Computational Mathematics Division, Gaithersburg, MD.

出版信息

ArXiv. 2022 Jun 28:arXiv:2206.14316v2.

PMID:35795812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9258291/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the importance and challenges of correctly interpreting antibody test results. Identification of positive and negative samples requires a classification strategy with low error rates, which is hard to achieve when the corresponding measurement values overlap. Additional uncertainty arises when classification schemes fail to account for complicated structure in data. We address these problems through a mathematical framework that combines high dimensional data modeling and optimal decision theory. Specifically, we show that appropriately increasing the dimension of data better separates positive and negative populations and reveals nuanced structure that can be described in terms of mathematical models. We combine these models with optimal decision theory to yield a classification scheme that better separates positive and negative samples relative to traditional methods such as confidence intervals (CIs) and receiver operating characteristics. We validate the usefulness of this approach in the context of a multiplex salivary SARS-CoV-2 immunoglobulin G assay dataset. This example illustrates how our analysis: (i) improves the assay accuracy (e.g. lowers classification errors by up to 42 % compared to CI methods); (ii) reduces the number of indeterminate samples when an inconclusive class is permissible (e.g. by 40 % compared to the original analysis of the example multiplex dataset); and (iii) decreases the number of antigens needed to classify samples. Our work showcases the power of mathematical modeling in diagnostic classification and highlights a method that can be adopted broadly in public health and clinical settings.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行凸显了正确解读抗体检测结果的重要性和挑战。识别阳性和阴性样本需要一种错误率低的分类策略,而当相应的测量值重叠时,这很难实现。当分类方案未能考虑数据中的复杂结构时,会产生额外的不确定性。我们通过一个结合高维数据建模和最优决策理论的数学框架来解决这些问题。具体而言,我们表明适当地增加数据维度能更好地分离阳性和阴性群体,并揭示可以用数学模型描述的细微结构。我们将这些模型与最优决策理论相结合,得出一种相对于传统方法(如置信区间(CI)和受试者操作特征)能更好地分离阳性和阴性样本的分类方案。我们在多重唾液SARS-CoV-2免疫球蛋白G检测数据集的背景下验证了这种方法的有效性。这个例子说明了我们的分析如何:(i)提高检测准确性(例如,与CI方法相比,分类错误率降低多达42%);(ii)在允许不确定类别的情况下减少不确定样本的数量(例如,与示例多重数据集的原始分析相比减少40%);以及(iii)减少分类样本所需的抗原数量。我们的工作展示了数学建模在诊断分类中的力量,并突出了一种可在公共卫生和临床环境中广泛采用的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/3e0d12191dc2/nihpp-2206.14316v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/039bf23f515a/nihpp-2206.14316v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/10a75cc39858/nihpp-2206.14316v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/728a3193670c/nihpp-2206.14316v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/3e0d12191dc2/nihpp-2206.14316v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/039bf23f515a/nihpp-2206.14316v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/10a75cc39858/nihpp-2206.14316v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/728a3193670c/nihpp-2206.14316v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a0/9759033/3e0d12191dc2/nihpp-2206.14316v2-f0004.jpg

相似文献

1
Modeling in higher dimensions to improve diagnostic testing accuracy: theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays.高维建模以提高诊断测试准确性:基于多重唾液的SARS-CoV-2抗体检测的理论与实例
ArXiv. 2022 Jun 28:arXiv:2206.14316v2.
2
Modeling in higher dimensions to improve diagnostic testing accuracy: Theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays.高维建模以提高诊断检测准确性:基于多重唾液的 SARS-CoV-2 抗体检测的理论与实例。
PLoS One. 2023 Mar 13;18(3):e0280823. doi: 10.1371/journal.pone.0280823. eCollection 2023.
3
Optimal decision theory for diagnostic testing: Minimizing indeterminate classes with applications to saliva-based SARS-CoV-2 antibody assays.最优诊断检测决策理论:最小化不确定类别及其在基于唾液的 SARS-CoV-2 抗体检测中的应用。
Math Biosci. 2022 Sep;351:108858. doi: 10.1016/j.mbs.2022.108858. Epub 2022 Jun 14.
4
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses.优化多重口腔液 SARS-CoV-2 IgG 检测性能的方法学方法及其与血清学和中和抗体反应的相关性。
J Immunol Methods. 2023 Mar;514:113440. doi: 10.1016/j.jim.2023.113440. Epub 2023 Feb 10.
5
Optimal Decision Theory for Diagnostic Testing: Minimizing Indeterminate Classes with Applications to Saliva-Based SARS-CoV-2 Antibody Assays.诊断检测的最优决策理论:通过应用于基于唾液的SARS-CoV-2抗体检测来最小化不确定类别
ArXiv. 2022 Jan 31:arXiv:2202.00494v1.
6
Optimal classification and generalized prevalence estimates for diagnostic settings with more than two classes.针对具有两个以上类别的诊断设置的最优分类和广义患病率估计。
Math Biosci. 2023 Apr;358:108982. doi: 10.1016/j.mbs.2023.108982. Epub 2023 Feb 17.
7
Classification under uncertainty: data analysis for diagnostic antibody testing.不确定性分类:诊断性抗体检测数据分析。
Math Med Biol. 2021 Aug 15;38(3):396-416. doi: 10.1093/imammb/dqab007.
8
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.用于鉴定 SARS-CoV-2 感染血清学特征的多重分析:基于抗体的诊断和机器学习研究。
Lancet Microbe. 2021 Feb;2(2):e60-e69. doi: 10.1016/S2666-5247(20)30197-X. Epub 2020 Dec 21.
9
A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.用于 SARS-CoV-2 感染的多重非侵入性唾液抗体检测及其在基于邮件的人群调查中的应用。
Microbiol Spectr. 2021 Oct 31;9(2):e0069321. doi: 10.1128/Spectrum.00693-21. Epub 2021 Sep 15.
10
Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.作者回复:在德国首次大流行期间,工人的职业与 SARS-CoV-2 感染风险:潜在的偏见。
Scand J Work Environ Health. 2022 Sep 1;48(7):588-590. doi: 10.5271/sjweh.4061. Epub 2022 Sep 25.

本文引用的文献

1
Optimal decision theory for diagnostic testing: Minimizing indeterminate classes with applications to saliva-based SARS-CoV-2 antibody assays.最优诊断检测决策理论:最小化不确定类别及其在基于唾液的 SARS-CoV-2 抗体检测中的应用。
Math Biosci. 2022 Sep;351:108858. doi: 10.1016/j.mbs.2022.108858. Epub 2022 Jun 14.
2
A statistical model of COVID-19 testing in populations: effects of sampling bias andtesting errors.人群中 COVID-19 检测的统计模型:抽样偏差和检测误差的影响。
Philos Trans A Math Phys Eng Sci. 2022 Jan 10;380(2214):20210121. doi: 10.1098/rsta.2021.0121. Epub 2021 Nov 22.
3
Longitudinal analysis of antibody decay in convalescent COVID-19 patients.
恢复期 COVID-19 患者抗体衰减的纵向分析。
Sci Rep. 2021 Aug 18;11(1):16796. doi: 10.1038/s41598-021-96171-4.
4
Classification under uncertainty: data analysis for diagnostic antibody testing.不确定性分类:诊断性抗体检测数据分析。
Math Med Biol. 2021 Aug 15;38(3):396-416. doi: 10.1093/imammb/dqab007.
5
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva.人群中 COVID-19 的血清学研究:唾液中 SARS-CoV-2 特异性抗体反应。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02204-20.
6
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.SARS-CoV-2 S1 和 N 基于的血清学检测方法显示 COVID-19 患者中快速的血清转化和特异性抗体应答的诱导。
Sci Rep. 2020 Oct 6;10(1):16561. doi: 10.1038/s41598-020-73491-5.
7
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.四种血清学检测方法在不同人群血清样本中检测抗 SARS-CoV-2 抗体的比较。
Sci Transl Med. 2020 Sep 2;12(559). doi: 10.1126/scitranslmed.abc3103. Epub 2020 Aug 17.
8
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.ORF8 和 ORF3b 抗体是 SARS-CoV-2 早期和晚期感染的准确血清学标志物。
Nat Immunol. 2020 Oct;21(10):1293-1301. doi: 10.1038/s41590-020-0773-7. Epub 2020 Aug 17.
9
COVID-19 pathophysiology: A review.新型冠状病毒肺炎的病理生理学:综述。
Clin Immunol. 2020 Jun;215:108427. doi: 10.1016/j.clim.2020.108427. Epub 2020 Apr 20.
10
Principles for high-quality, high-value testing.高质量、高价值检测的原则。
Evid Based Med. 2013 Feb;18(1):5-10. doi: 10.1136/eb-2012-100645. Epub 2012 Jun 27.